logo
Bassett Medical Center Earns Prestigious Magnet Designation for Nursing Excellence

Bassett Medical Center Earns Prestigious Magnet Designation for Nursing Excellence

Business Upturn25-04-2025
Cooperstown, New York, April 25, 2025 (GLOBE NEWSWIRE) — Bassett Medical Center in Cooperstown, NY, has achieved Magnet® Recognition for Nursing Excellence, the highest national honor a hospital can attain for nurse satisfaction, patient outcomes, and nursing quality. On April 23, officials from the American Nurses Credentialing Center (ANCC) gathered Bassett Medical Center nurses, other caregivers, and leaders for a video conference to announce they had earned the distinction. When officials delivered the news, cheers were heard throughout the room as clinical staff celebrated all the hard work that led to this milestone achievement.
With this credential, Bassett Medical Center joins an elite group of approximately 10% of U.S. hospitals. The rigorous process involves years of in-depth review, research, and process improvements to demonstrate an organization's nurses and nursing leaders adhere to stringent principles for quality care, strategic planning, and professional development. This included a more than 1,500 page application, public comment period, and an ANCC site visit in February 2025, during which more than 100 employees and community members were interviewed in 70 survey sessions.
'This designation means everything to the nurses at Bassett Medical Center and is truly a testament to their talent, skill, and dedication to excellence,' says Christina Curcio, MSN-RN, Chief Nursing Officer and Vice President of Nursing at Basset Medical Center. 'It's gratifying to see so many years of hard work by so many people come to fruition. Magnet designation is an indication to patients and the public, as well as current and future Bassett nurses, that Bassett Medical Center meets the most rigorous, evidence-based standards.'
Bassett Medical Center not only earned Magnet designation, but the ANCC also recognized the hospital for several exemplars, which are performance-based results and achievements that make Bassett Medical Center an exemplary institution nationally among Magnet facilities. Bassett Medical Center's exemplars include best practices in: Preventing hospital-acquired pressure injuries
Preventing hospital-acquired blood stream infections
Quickness of triaging and treating patients who present with heart attacks (door to procedure room times outperform national benchmarks)
Nursing collaboration, shared governance, and clinical nurse empowerment
'Transformational leadership, structural empowerment, innovation, exemplary professional practice, and empirical quality results are the five components of the Magnet model and the nurses at Bassett Medical Center demonstrated their commitment and achievement in these areas, making this designation possible,' says Samuel Campbell, MS, CCRN, CNML, Director of Nursing Quality and Education and Magnet Program Director for Bassett Healthcare Network. 'Congratulations on all on this well-deserved honor.'
The ANCC Magnet Recognition Program designates organizations worldwide where leaders successfully align nursing strategic goals to improve the organization's patient outcomes. The program provides a roadmap to nursing excellence, which benefits the whole of an organization. To nurses, Magnet Recognition means education and development through every career stage, which leads to greater autonomy at the bedside. To patients, it means the very best care, delivered by nurses who are supported to be the very best that they can be.
Magnet recognition is the gold standard for nursing excellence and is a factor when the public judges healthcare organizations. U.S. News & World Report's annual showcase of 'America's Best Hospitals' includes Magnet recognition in its ranking criteria for quality of inpatient care.
'The nurses at Bassett Medical Center have made the entire network proud with this achievement,' says Angela Belmont, DNP, RN, NEA-BC, Senior Vice President and Chief Nurse Executive at Bassett Healthcare Network. 'Magnet designation is not just a validation of our nursing excellence but a testament to our unwavering dedication to delivering exceptional patient care. Congratulations on this most prestigious achievement. We have reached the summit.'
###
About Bassett Healthcare Network
Bassett Healthcare Network is an integrated health system that provides care and services to people living in a 5,600 square mile region in upstate New York. The organization includes five corporately affiliated hospitals, over two dozen community-based health centers, more than 20 school-based health centers, two skilled nursing facilities, and other health partners in related fields. To learn more about services available throughout the Bassett Healthcare Network, visit bassett.org. Follow Bassett on Facebook, X, and LinkedIn. Bassett Healthcare Network is an equal opportunity provider and employer.
About ANCC's Magnet Recognition Program
The Magnet Recognition Program — administered by the American Nurses Credentialing Center, the largest and most prominent nurses credentialing organization in the world — identifies health care organizations that provide the very best in nursing care and professionalism in nursing practice. The Magnet Recognition Program is the highest national honor for nursing excellence and provides consumers with the ultimate benchmark for measuring quality of care. For more information about the Magnet Recognition Program and current statistics, visit www.nursingworld.org/magnet.
Attachments
Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Lupin launches Ipratropium Bromide Nasal Solution (Nasal Spray) in the US market
Lupin launches Ipratropium Bromide Nasal Solution (Nasal Spray) in the US market

Business Upturn

time10 hours ago

  • Business Upturn

Lupin launches Ipratropium Bromide Nasal Solution (Nasal Spray) in the US market

Lupin Limited has announced the launch of its generic version of Ipratropium Bromide Nasal Solution in the United States. The product will be available in both 0.03% and 0.06% strengths and is a therapeutic equivalent to Boehringer Ingelheim's Atrovent® Nasal Spray. This launch marks Lupin's latest addition to its U.S. generic portfolio. The Ipratropium Bromide Nasal Solution 0.03% is used to provide symptomatic relief of rhinorrhea linked to both allergic and nonallergic perennial rhinitis in adults and children aged six and above. The 0.06% version targets rhinorrhea symptoms associated with the common cold or seasonal allergic rhinitis in adults and children aged five and older. According to IQVIA data for the 12 months ending May 2025, the reference drug Atrovent® recorded estimated annual U.S. sales of approximately USD 63 million. With this launch, Lupin aims to tap into the niche respiratory care segment while expanding access to affordable treatment options for patients in the U.S. Ahmedabad Plane Crash Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at

U.S. Leads North America Syringe Infusion Pumps Market Amid Rising Hospitalizations and Chronic Diseases
U.S. Leads North America Syringe Infusion Pumps Market Amid Rising Hospitalizations and Chronic Diseases

Yahoo

time12 hours ago

  • Yahoo

U.S. Leads North America Syringe Infusion Pumps Market Amid Rising Hospitalizations and Chronic Diseases

The North America Syringe Infusion Pumps Market is projected to grow from USD 645.1 million in 2024 to USD 1.04 billion by 2030, at a CAGR of 8.40%. Key drivers include an increase in chronic diseases and surgeries, technological advancements, and the expansion of home healthcare. The market is bolstered by favorable regulations and major regional growth. North American Syringe Infusion Pumps Market Dublin, July 04, 2025 (GLOBE NEWSWIRE) -- The "North America Syringe Infusion Pumps Market Size, Share & Trends Analysis Report by Disease Indication (Pediatrics/neonatology, Chemotherapy, Diabetes, Gastroenterology), End-use (Hospitals, Homecare), Country with Growth Forecasts, 2025-2030" report has been added to North America Syringe Infusion Pumps Market was valued at USD 645.1 million in 2024, and is projected to reach USD 1.04 billion by 2030, rising at a CAGR of 8.40%. The market is experiencing substantial growth driven by the increasing prevalence of chronic diseases, affecting approximately six in ten adults and necessitating precise, continuous medication delivery for conditions such as cancer and diabetes. The rising number of surgical procedures and ICU admissions further amplifies demand for these pumps, crucial for delivering anesthetics and critical care medications. This is especially true considering the projected increase in U.S. hospitalizations from 36 million in 2025 to 40 million by advancements in smart infusion technologies, including Dose Error Reduction Systems (DERS) and EHR compatibility, are pivotal in enhancing medication safety and efficiency, as North America leads in their adoption. The expanding home healthcare and ambulatory care sectors, fueled by an aging population and cost-containment strategies, are increasing the demand for portable, user-friendly syringe pumps for safe medication delivery outside hospitals. Favorable regulatory environments and reimbursement policies further support the sustained growth and innovation within the America Syringe Infusion Pumps Market Report Highlights: Pediatrics/neonatology held the largest revenue share of over 25% in 2024, owing to the critical need for precise drug delivery for newborns and infants, coupled with advancements in safety technologies and NICU/PICU investments The chemotherapy segment is projected to grow at the fastest CAGR over the forecast period Market growth is fueled by the critical need for precise syringe pump delivery of potent drugs, supported by safety features, and the increasing number of cancer cases. Hospitals dominated the market with around 40.0% of the total revenue share in 2024 due to high demand for precise drug delivery in critical care and diverse applications. Homecare is projected to grow at the fastest CAGR of 8.7% over the forecast period. The U.S. dominated the North American syringe infusion pumps market, supported by the high prevalence of chronic diseases and growing national healthcare expenditure. Companies Featured The major companies featured in this North America Syringe Infusion Pumps market report include: Baxter B. Braun Medical Inc. Fresenius Kabi AG ICU Medical, Inc. Micrel Medical Devices SA Boston Scientific Corporation BD Terumo Corporation Moog Inc. IRadimed Corporation CODAN Companies ACROMED Key Attributes: Report Attribute Details No. of Pages 80 Forecast Period 2024 - 2030 Estimated Market Value (USD) in 2024 $645.1 Million Forecasted Market Value (USD) by 2030 $1040 Million Compound Annual Growth Rate 8.4% Regions Covered North America Key Topics Covered: Chapter 1. Methodology and ScopeChapter 2. Executive Summary2.1. Market Outlook2.2. Segment Outlook2.3. Competitive InsightsChapter 3. North America Syringe Infusion Pumps Market Variables, Trends & Scope3.1. Market Lineage Outlook3.2. Market Dynamics3.3. North America Syringe Infusion Pumps Market Analysis Tools3.3.1. Industry Analysis - Porter's3.3.2. PESTEL AnalysisChapter 4. North America Syringe Infusion Pumps Market: Disease Indication Estimates & Trend Analysis4.1. Disease Indication Segment Dashboard4.2. North America Syringe Infusion Pumps Market: Disease Indication Movement Analysis4.3. North America Syringe Infusion Pumps Market Size & Trend Analysis, by Disease Indication, 2018 to 2030 (USD Million)4.4. Chemotherapy4.5. Diabetes4.6. Gastroenterology4.7. Analgesia/Pain Management4.8. Pediatrics/Neonatology4.9. Hematology4.10. OthersChapter 5. North America Syringe Infusion Pumps Market: End Use Estimates & Trend Analysis5.1. End Use Segment Dashboard5.2. North America Syringe Infusion Pumps Market: End Use Movement Analysis5.3. North America Syringe Infusion Pumps Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)5.4. Hospitals5.5. Homecare5.6. Others (ASC, Nursing Homes, Rehabilitation Centers)Chapter 6. North America Syringe Infusion Pumps Market: Country Estimates & Trend Analysis6.1. Country Market Dashboard6.2. Country Market Share Analysis, 2024 & 20306.3. North America Syringe Infusion Pumps Market by country: Key Takeaways6.4. U.S.6.5. Canada6.6. MexicoChapter 7. Competitive Landscape7.1. Recent Developments & Impact Analysis, By Key Market Participants7.2. Company/Competition Categorization7.3. Vendor Landscape7.3.1. Key company heat map analysis, 20247.4. Company Profiles Baxter B. Braun Medical Inc. Fresenius Kabi AG ICU Medical, Inc. Micrel Medical Devices SA Boston Scientific Corporation BD Terumo Corporation Moog Inc. IRadimed Corporation CODAN Companies ACROMED For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment North American Syringe Infusion Pumps Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

U.S. Complementary and Alternative Medicine Market Competitive Landscape 2025, with Gaia Herbs, Herb Pharm, Pure Encapsulations, NOW Health Group, Nature's Way, Solgar, Twinlab, Ayush Herbs, and more
U.S. Complementary and Alternative Medicine Market Competitive Landscape 2025, with Gaia Herbs, Herb Pharm, Pure Encapsulations, NOW Health Group, Nature's Way, Solgar, Twinlab, Ayush Herbs, and more

Yahoo

time13 hours ago

  • Yahoo

U.S. Complementary and Alternative Medicine Market Competitive Landscape 2025, with Gaia Herbs, Herb Pharm, Pure Encapsulations, NOW Health Group, Nature's Way, Solgar, Twinlab, Ayush Herbs, and more

The U.S. Complementary and Alternative Medicine Market offers significant growth opportunities, driven by increased consumer interest in wellness and non-traditional medicine. Key trends include integration with conventional healthcare, rising chronic and stress-related health issues, and mainstream acceptance of therapies like herbal supplements and mindfulness practices. However, challenges such as regulatory inconsistencies and quality control issues remain. U.S. Complementary and Alternative Medicine Market Dublin, July 04, 2025 (GLOBE NEWSWIRE) -- The "United States Complementary and Alternative Medicine Market, By Region, Competition, Forecast & Opportunities, 2020-2030F" has been added to United States Complementary and Alternative Medicine Market was valued at USD 34.82 Billion in 2024, and is expected to reach USD 125.94 Billion by 2030, rising at a CAGR of 23.87%. The market is expanding rapidly as consumer interest in wellness-oriented lifestyles grows and individuals increasingly explore treatment options beyond traditional medicine. Therapies like acupuncture, homeopathy, naturopathy, energy healing, and aromatherapy are gaining traction across diverse demographics for managing both acute and chronic health concerns. CAM offerings are increasingly integrated with fitness memberships, corporate wellness programs, and digital health subscriptions, contributing to their mainstream acceptance. The popularity of herbal infusions, detox products, and plant-based diets further reflects a cultural pivot toward natural health solutions. According to the NCCIH's 2023 survey, approximately 40% of American adults and 12% of children use complementary therapies. CAM services are being widely incorporated into holistic clinics, hospitals, and telehealth platforms, covering modalities such as yoga, mindfulness, chiropractic care, and herbal supplementation. The younger population is adopting Reiki, sound healing, and crystal therapy, while older adults seek non-invasive methods for pain and sleep disorders. CAM visibility is amplified by wearable health tech, social media influencers, and expanded retail presence in pharmacies and online marketplaces. Key Market Drivers Increase in Chronic and Stress-Related Health Conditions The growing incidence of chronic and stress-induced health conditions is a key driver of the United States Complementary and Alternative Medicine Market. Chronic diseases like cardiovascular disorders, diabetes, arthritis, and respiratory ailments continue to rise, affecting a significant portion of the U.S. population. As of 2023, CDC data shows 6 in 10 U.S. adults live with at least one chronic condition, and 4 in 10 have two or more. Patients are increasingly turning to CAM therapies for their holistic and less invasive approach to long-term disease management. Stress-related issues are also prevalent due to modern lifestyle demands. The American Psychological Association reported that 77% of Americans frequently experience physical symptoms from stress, and 73% report psychological effects. CAM practices such as meditation, acupuncture, herbal therapy, and mindfulness are gaining popularity as non-drug alternatives for mental and emotional well-being. Clinicians are recognizing the value of integrative care models that blend conventional and complementary therapies to address both physical and emotional dimensions of health. The rising emphasis on self-care, wellness, and preventive strategies is further fueling CAM's appeal. Key Market Challenges Lack of Standardized Regulations and Quality Control One of the most significant challenges facing the U.S. CAM market is the lack of consistent regulatory frameworks and standardized quality controls. Unlike conventional pharmaceuticals, many CAM products - including herbal supplements and traditional remedies - do not undergo uniform evaluation for safety and efficacy. This regulatory inconsistency creates uncertainty for both consumers and manufacturers, limiting broader adoption and integration into mainstream healthcare. Quality assurance is another critical issue. Variability in ingredient sourcing, formulation, and production processes leads to inconsistent product quality and therapeutic outcomes. Botanical components, for example, can vary significantly in potency depending on region, harvesting practices, and processing methods. These inconsistencies raise concerns about contamination and mislabeling. The absence of robust quality standards can reduce consumer trust and expose producers to legal risks. The lack of regulatory clarity also discourages investment and innovation, delaying the development of validated, evidence-based CAM solutions. Key Market Trends Integration of CAM into Conventional Healthcare Systems A prominent trend in the U.S. CAM market is its growing integration into mainstream healthcare settings. The Department of Veterans Affairs has significantly expanded its use of Complementary and Integrative Health (CIH) practices to support pain management, mental health, and overall well-being. This move represents a broader push toward patient-centered care that includes both medical and holistic treatment options. Government-backed initiatives further reflect this integration. For instance, in 2023, the Department of Health and Human Services launched a national strategy emphasizing Food Is Medicine (FIM) programs, aligning with CAM's foundational principles. These developments signal increasing institutional support for CAM therapies as part of broader healthcare delivery models. Hospitals, insurers, and public health organizations are recognizing the value of non-invasive, cost-effective interventions in managing chronic diseases and improving patient satisfaction. This institutional adoption is expected to accelerate as more clinical data validates CAM's efficacy and safety. Key Market Players Gaia Herbs, Inc. Herb Pharm, LLC Pure Encapsulations, LLC NOW Health Group, Inc. Nature's Way Products, LLC Solgar, Inc. Traditional Medicinals, Inc. Twinlab Consolidated Holdings, Inc. Ayush Herbs, Inc. Integrative Therapeutics Key Attributes: Report Attribute Details No. of Pages 84 Forecast Period 2024 - 2030 Estimated Market Value (USD) in 2024 $34.82 Billion Forecasted Market Value (USD) by 2030 $125.94 Billion Compound Annual Growth Rate 23.8% Regions Covered United States Report Scope: In this report, the United States Complementary and Alternative Medicine Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below: United States Complementary and Alternative Medicine Market, By Intervention: Traditional Alternative Medicine/Botanicals Mind Healing Body Healing External Energy Aromatherapy United States Complementary and Alternative Medicine Market, By Distribution Method: Direct Sales E-sales Distance Correspondence United States Complementary and Alternative Medicine Market, By Region: North-East Mid-West West South For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment U.S. Complementary and Alternative Medicine Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Sign in to access your portfolio

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store